BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 31823354)

  • 21. Genetic variants in pachyonychia congenita-associated keratins increase susceptibility to tooth decay.
    Duverger O; Carlson JC; Karacz CM; Schwartz ME; Cross MA; Marazita ML; Shaffer JR; Morasso MI
    PLoS Genet; 2018 Jan; 14(1):e1007168. PubMed ID: 29357356
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A KRT6A mutation p.Ile462Asn in a Chinese family with pachyonychia congenita, and identification of maternal mosaicism: a case report.
    Li Y; Wang Y; Ming Y; Chaolan P; Jia Z; Cheng N; Qiaoyu C; Li M; Tianyi X
    BMC Med Genomics; 2021 Nov; 14(1):259. PubMed ID: 34724947
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genotype-phenotype correlations among pachyonychia congenita patients with K16 mutations.
    Fu T; Leachman SA; Wilson NJ; Smith FJ; Schwartz ME; Tang JY
    J Invest Dermatol; 2011 May; 131(5):1025-8. PubMed ID: 21160496
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The histopathological features of the nail plate in pachyonychia congenita.
    Stewart CL; Takeshita J; Hansen CD; Rubin AI
    J Cutan Pathol; 2020 Apr; 47(4):357-362. PubMed ID: 31845382
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A KRT16 mutation in the first Chinese pedigree with Pachyonychia congenita and review of the literatures.
    Xu Q; Zhang Q; Tang L; Jin L; Wang X; Kan L; Zheng X; Yang S
    J Cosmet Dermatol; 2019 Dec; 18(6):1930-1934. PubMed ID: 30859684
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pachyonychia congenita type 2 (Jackson-Lawler syndrome) or PC-17: case report.
    Morais P; Peralta L; Loureiro M; Coelho S
    Acta Dermatovenerol Croat; 2013; 21(1):48-51. PubMed ID: 23683487
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Collapse of the keratin filament network through the expression of mutant keratin 6c observed in a case of focal plantar keratoderma.
    Kubo A; Oura Y; Hirano T; Aoyama Y; Sato S; Nakamura K; Takae Y; Amagai M
    J Dermatol; 2013 Jul; 40(7):553-7. PubMed ID: 23662636
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Keratin K6c mutations cause focal palmoplantar keratoderma.
    Wilson NJ; Messenger AG; Leachman SA; O'Toole EA; Lane EB; McLean WH; Smith FJ
    J Invest Dermatol; 2010 Feb; 130(2):425-9. PubMed ID: 19609311
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genotype‒Structurotype‒Phenotype Correlations in Patients with Pachyonychia Congenita.
    Wu TT; Eldirany SA; Bunick CG; Teng JMC
    J Invest Dermatol; 2021 Dec; 141(12):2876-2884.e4. PubMed ID: 34116063
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pachyonychia Congenita Project: Advancing Research and Drug Development through Collaboration.
    Schwartz JN; Evans HA; O'toole EA; Hansen CD
    Keio J Med; 2023 Dec; ():. PubMed ID: 38072449
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mutation p.Leu128Pro in the 1A domain of K16 causes pachyonychia congenita with focal palmoplantar keratoderma in a Chinese family.
    Dai L; Wu J; Guo H; Huang Y; Zhang K; Liu D; Fu L; Wu Y; Guan X; Bai Y; Liao Q
    Eur J Pediatr; 2014 Jun; 173(6):737-41. PubMed ID: 24357266
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Proteomic profiling reveals KRT6C as a probable hereterodimer partner for KRT9: New insights into re-classifying epidermolytic palmoplantar keratoderma (EPPK) and a milder form of pachyonychia congenita (PC-K6c) as a group of genetic cutaneous disorders.
    Li P; Qi J; Zhong Y; Ding A; Xiao H
    J Proteomics; 2023 Sep; 287():104971. PubMed ID: 37467889
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pachyonychia Congenita (K16) with Unusual Features and Good Response to Acitretin.
    Almutawa F; Thusaringam T; Watters K; Gayden T; Jabado N; Sasseville D
    Case Rep Dermatol; 2015; 7(2):220-6. PubMed ID: 26464567
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pachyonychia congenita type 2, N92S mutation of keratin 17 gene: clinical features, mutation analysis and pathological view.
    Cogulu O; Onay H; Aykut A; Wilson NJ; Smith FJ; Dereli T; Ozkinay F
    Eur J Pediatr; 2009 Oct; 168(10):1269-72. PubMed ID: 19107515
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A novel missense mutation L468Q of keratin 6a in pachyonychia congenita type 1.
    Zhou HL; Yang S; Gao M; Zhao XY; Zhu YG; Li W; Ren YQ; Liang YH; Du WH; Zhang XJ
    J Eur Acad Dermatol Venereol; 2007 Mar; 21(3):351-5. PubMed ID: 17309457
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A spectrum of mutations in keratins K6a, K16 and K17 causing pachyonychia congenita.
    Liao H; Sayers JM; Wilson NJ; Irvine AD; Mellerio JE; Baselga E; Bayliss SJ; Uliana V; Fimiani M; Lane EB; McLean WH; Leachman SA; Smith FJ
    J Dermatol Sci; 2007 Dec; 48(3):199-205. PubMed ID: 17719747
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Keratin 16-null mice develop palmoplantar keratoderma, a hallmark feature of pachyonychia congenita and related disorders.
    Lessard JC; Coulombe PA
    J Invest Dermatol; 2012 May; 132(5):1384-91. PubMed ID: 22336941
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Increased pachyonychia congenita severity in patients with concurrent keratin and filaggrin mutations.
    Gruber R; Wilson NJ; Smith FJ; Grabher D; Steinwender L; Fritsch PO; Schmuth M
    Br J Dermatol; 2009 Dec; 161(6):1391-5. PubMed ID: 19785597
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mutations in a keratin 6 isomer (K6c) cause a type of focal palmoplantar keratoderma.
    Bowden PE
    J Invest Dermatol; 2010 Feb; 130(2):336-8. PubMed ID: 20081885
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.